1Beldent V, Michaud A, Wei L, et al. Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J Biol Chem, 1993,268(35 ) :26428 -26434. 被引量：1
3Zatz R, Dunn BR, Meyer TW, et al. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest, 1986,77(6) :1925 -1930. 被引量：1
4Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensinconverting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med, 1993,329(20) :1456 -1462. 被引量：1
5Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001,345 (12) :861 - 869. 被引量：1
6Lewis E J, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med, 2001,345 (12) : 851 - 860. 被引量：1
7Parving HH, Lehnen H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med,2001,345(12) :870 -878. 被引量：1
8Danser AH, Derkx FH, Schalekamp MA, et al. Determinants of interindividual variation of renin and prorenin concentrations: Evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens, 1998,16 ( 6 ) : 853 - 862. 被引量：1
9Daneman D, Crompton CH, Balfe JW, et al. Plasma prorenin as an early marker of nephropathy in diabetic (iddm) adolescents. Kidney Int, 1994,46(4) :1154 - 1159. 被引量：1
10Veniant M, Menard J, Bruneval P, et al. Vascular damage without hypertension in transgenic rats expressing prorenin exclusively in the liver. J Clin Invest, 1996,98(9):1966- 1970. 被引量：1
